Delivery Order SPE2DB20D2104-SPE2DB24FT65B
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,799.97 for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 5, 2022 with an ultimate completion date of April 6, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D1050|SPE2DB24FH50M) with a ceiling value of $5,084.17. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,921.07 fixed-price delivery order is for the pharmaceutical product DUPIXENT 200 MG/1.14 ML PEN 1.14ML, with a completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $41,935.36 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA). The contract covers the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,100.61 firm fixed-price delivery order is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $9,917.28 for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of February 12, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $22,504.08 for the supply of DUPIXENT 200 MG/1.14 ML SYRING 1.14ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 29, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor, holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $49,406.60 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a completion date of May 6, 2024. The award was made on May 3, 2024, and the contract type is Firm Fixed Price. This contract award does not have a set-aside...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract has an award value of $2,628.42 and is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a specialty pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,858.13 and a period of performance through January 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on January 30, 2024 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT65BDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,915.46 for 4564299038 - DUPIXENT 200 MG/1.14 ML PEN 1.14ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 16, 2024, with a completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 4/16/24 |